{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/gossamer-bio-inc-goss-faces-securities-class-action-amid-80-drop-on-phase-3-prosera-trial-failure-hagens-berman-302762911.html", "message": "News view counter 703819 successfully enlarged"}